Unitika Confirms that L-arabinose Helps Inhibit Obesity and Diabetes.Tokyo, Japan, May 11, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Unitika announced on May 9 the results of its recent research on L-arabinose, a monosaccharide monosaccharide: see carbohydrate. monosaccharide Any of the simple sugars that serve as building blocks for carbohydrates. They are classified based on their backbone of carbon (C) atoms: Trioses have three carbon atoms, tetroses four, pentoses extracted from sugar beet. The research has found that L-arabinose demonstrates a potential to inhibit obesity and type 2 diabetes type 2 diabetes n. See diabetes mellitus. . Specifically, in a mice experiment, the company confirmed that a 19-week administration of L-arabinose prevents weight gain, reduces the rise of the fasting blood sugar level and the insulin resistance Insulin Resistance Definition Insulin resistance is not a disease as such but rather a state or condition in which a person's body tissues have a lowered level of response to insulin, a hormone secreted by the pancreas that helps to regulate the level index. Details of the research will be presented at the 60th Annual Meeting of the Japanese Society of Nutrition and Food Science to be held in Shizuoka from May 19. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion